VEGFA and atrophic macular degeneration: For geographic atrophy (GA), complement inhibitors reduce immune-mediated injury by dampening complement overactivation, while in neovascular AMD, anti-VEGF agents help re-seal the outer barrier and reduce inflammatory exudation (18, 49, 71, 72).